Geng, Yingnan
Duan, Huichuan
Xu, Liang
Witman, Nevin
Yan, Bingqian
Yu, Zheyuan
Wang, Huijing
Tan, Yao
Lin, Liqin
Li, Dong
Bai, Shanshan
Fritsche-Danielson, Regina
Yuan, Jie http://orcid.org/0000-0003-3009-168X
Chien, Kenneth http://orcid.org/0000-0002-2759-8378
Wei, Min http://orcid.org/0000-0001-9629-6413
Article History
Received: 22 August 2019
Accepted: 16 December 2020
First Online: 19 January 2021
Competing interests
: R.F.D. is Senior VP of Astrazeneca and global leader of the CVRM; K.C. is a senior advisor and member of the AZ. S.B. and is recipient of a grant from the joint KI-AZ Integrated Cardiometabolic Center (ICMC); and Nevin Witman is supported in part by the ICMC. The remaining authors declare no competing interests.